Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmaceutical Consultation and Exchange Between the Pharmacy and the Hospital (EPHET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04811183
Recruitment Status : Recruiting
First Posted : March 23, 2021
Last Update Posted : July 27, 2021
Sponsor:
Information provided by (Responsible Party):
Hospices Civils de Lyon

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Investigators hypothesize that the implementation of a hospital pharmacy consultation and the transmission of its report to pharmacies may improve knowledge, adherence and encourage the development of pharmacist medication reviews. A before-and-after study of the implementation of pharmaceutical consultations will allow the investigators to evaluate the validity of the hypothesis.

Condition or disease Intervention/treatment
Diabetes Behavioral: Pharmaceutical consultation

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Pharmaceutical Consultation and Exchange Between the Pharmacy and the Hospital
Actual Study Start Date : June 4, 2021
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Medicines

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Experimental group
Adult patients hospitalized with diabetes and polymedicated. Selected to benefit from a pharmaceutical consultation before their return home.
 Behavioral: Pharmaceutical consultation

Selection of patients for a pharmaceutical consultation with collection of non-opposition and scheduling of telephone interviews or by teleconsultations at one week after hospitalization.

Data collection through interviews using a telephone questionnaire (or by teleconsultation) one week after consultation. Elements on knowledge and adherence of treatment will be collected.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Evolution in the knowledge about the patient's condition [ Time Frame: One week ]

    Treatment knowledge, knowledge about the pathology and knowledge of hygienic and dietary measures will be assessed with a questionnaire giving a score from 0 to 2 -the higher the score, the better the outcome-.

    Comparison of the knowledge of the treatment between the first questionnaire conducted during the pharmaceutical consultation and the second questionnaire one week after the consultation.

    Statistical evaluation by comparative tests between the two questionnaires.


  2. Evolution in the adherence [ Time Frame: One week ]

    Evaluation of the patient's adherence to his treatment through a questionnaire giving a score between 0 to 6 -the higher the score, the better the outcome-. Comparison of the scores between the first questionnaire conducted during the pharmaceutical consultation and the second questionnaire one week after the consultation.

    Statistical evaluation by comparative tests between the two questionnaires.



Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult patient admitted in the endocrinology service for a type 2 Diabetes who has more than 5 concomitting treatments, on the way to returning home.
Criteria

Inclusion Criteria:

  • Adult patient admitted in the endocrinology service for a type 2 Diabetes who has more than 5 concomitant treatments
  • Adult patient that is being discharged for a return home
  • Good comprehension of French

Exclusion Criteria:

  • Bad comprehension of French
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04811183


Contacts
Layout table for location contacts
Contact: Xavier DODE 04 72 35 71 08 xavier.dode@chu-lyon.fr
Contact: Olivier RIBES 04 72 39 22 43 olivier.ribes@chu-lyon.fr

Locations
Layout table for location information
France
Hôpital Louis Pradel Recruiting
Bron, France, 69577
Contact: Xavier DODE, MD    04 72 35 71 08    xavier.dode@chu-lyon.fr   
Sponsors and Collaborators
Hospices Civils de Lyon
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Hospices Civils de Lyon
ClinicalTrials.gov Identifier: NCT04811183    
Other Study ID Numbers: 69HCL21_0197
First Posted: March 23, 2021    Key Record Dates
Last Update Posted: July 27, 2021
Last Verified: July 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Hospices Civils de Lyon:
pharmaceutical consultations
adherence